Eric M. Reiman, M.D.

Dr. Eric Reiman is Chief Executive Officer of the Banner Alzheimer’s Institutes, overseeing and spearheading initiatives at the Alzheimer’s institutes in Phoenix and Tucson and Banner Sun Health Research Institute in Sun City. He is also Director of the Arizona Alzheimer’s Consortium, Clinical Director of Neurogenomics at the Translational Genomics Research Institute (TGen), Professor of Psychiatry at the University of Arizona and University Professor of Neuroscience at Arizona State University. Dr. Reiman also serves our community as Chairman of the Board of the Flinn Foundation. A privately endowed, philanthropic grantmaking organization established in 1965 by Dr. Robert S. and Irene P. Flinn, its mission is to improve the quality of life in Arizona to benefit future generations. The Flinn Foundation is the steward  of Arizona’s Bioscience Roadmap, the longest-running, statewide bioscience strategic plan in the nation. The third iteration of the roadmap will be released in September 2025.

What does it take to deliver health innovations that help people living with or at risk for Alzheimer’s Disease?

“It will take the right prevention trials, methods, and enrolment strategies to rapidly test, find and approve prevention therapies in people at genetic or biomarker risk. It will take shared urgency, courage and commitment, new collaborative models, and extensive data sharing. It will take a multifaceted approach to optimise availability, affordability, and appropriate use of treatments. A suggested treatment will need to work, and we now have a chance to find out.”  ~ Dr. Eric Reiman  (Quote Source: The Lancet)